Platelet Suppressing Drugs in Arterial Disease^[*]

• 

^* Presented at the VIth International Congress on Thrombosis and Haemostasis, Philadelphia, Pa., June 27, 1977

• References

• 1 Acheson J, Danta G, Hutchinson EC. 1969; Controlled trial of Dipyridamole in cerebral vascular disease. British Medical Journal 1: 614
• 2 Acheson J, Hutchinson EC. 1972; Controlled trial of Clofibrate in cerebral vascular disease. Atherosclerosis 15: 177
• 3 Barnett HJM. 1977. Personal communication.
• 4 Blakely JA, Pogoriler G. 1977; Prospective trial of Sulfinpyrazone in the maintenance of patency following peripheral vascular surgery. Thrombosis and Haemostasis 38: 238
• 5 Blakely JA, Gent M. 1975 Platelets, drugs and longevity in a geriatric population. Platelets, Drugs and Thrombosis Symposium, Hamilton, Karger, Basel 284
• 6 Boston Collaborative Drug Surveillance 1972; Regular Aspirin intake and acute myocardial infarction. British Medical Journal 1: 440
• 7 Breddin K, Oberla K, Walter E. 1977; German-Austrian multicenter two years prospective study on the prevention of secondary myocardial infarction by ASA in comparison to Phenprocoumon and placebo. Thrombosis and Haemostasis 38: 168
• 8 The Coronary Drug Project Research Group 1976; Aspirin in coronary heart disease. Journal of Chronic Diseases 29: 625
• 9 Dale J. 1977; Prevention of arterial thromboembolism with acetylsalicylic acid in patients with prosthetic heart valves. Thrombosis and Haemostasis 38: 66
• 10 Elwood PC, Cochrane AL, Burr ML, Sweetnam PM, Williams G, Welsby E, Hughes SJ, Renton R. 1974; A randomized controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. British Medical Journal 1: 436
• 11 Evans G. 1972. Effect of platelet-suppressive agents on the incidence of amaurosis fugax and transient cerebral ischemia. In: Fletcher H, McDowell Robert WBRENNAN. (eds.) Cerebral Vascular Disease, Eighth Conference. 1973. Grune and Stratton Inc. 297.:
• 12 Fields WS, Lemak NA, Frankowski RF, Hardy RJ. 1977; Controlled trial of Aspirin in cerebral ischemia. Stroke 8 3 301
• 13 Five-Year Study by a Group of Physicians of the Newcastle Upon Tyne Region 1971; Trial of Clofibrate in the treatment of ischemic heart disease. British Medical Journal 4: 767
• 14 Freed M, Rosenthal A, Fyler D. 1974; Attempts to reduce arterial thrombosis after cardiac catherization in children: Use of percutaneous technique and aspirin. American Heart Journal 87 3 283
• 15 Friedewald WT, Halperin M. 1972; Clofibrate in ischemic heart disease. Annals of Internal Medicine 76 5 821
• 16 Hammond EC, Garfinkel L. 1975; Asprin and coronary heart disease: Findings of a prospective study. British Medical Journal 2: 269
• 17 Heady JA. 1973; A co-operative trial on the primary prevention of ischemic heart disease using Clofibrate: Design, methods and progress. Bulletin of the World Health Organization 48: 243
• 18 Heikinheimo R, Järvinen K. 1971; Acetylsalicylic acid and arteriosclerotic-thromboembolic diseases in the aged. Journal of the American Geriatric Society 19 5 403
• 19 Hynes KM, Gau GT, Rutherford BD, Kazmier FJ, Frye RL. 1973; Effect of aspirin on brachial artery occlusion following brachial arteriotomy for coronary arteriography. Circulation 47: 554
• 20 Kaegi A, Pineo GF, Shimizu A, Trivedi H, Hirsh J, Gent M. 1975; The role of Sulfinpyrazone in the prevention of arterio-venous shunt thrombosis. Circulation 52: 497
• 21 Mcenany M, De Sanctis RW, Harthorne JW, Mundth ED, Wintraub RM, Austen WG, Salzman EW. 1976; Effect of antithrombotic therapy on aorto-coronary vein graft patency rates. Circulation 53 2 124
• 22 Report by a Research Committee of the Scottish Society of Physicians 1971; Ischemic heart disease: A secondary prevention trial using Clofibrate. British Medical Journal 4: 775
• 23 Sullivan JM, Harken DE, Gorlin R. 1971; Pharmacologic control of thromboembolic complications of cardiac valve replacement. New England Journal of Medicine 284: 1391